ODT
Odonate Therapeutics, Inc.
Director and 10% owner Aaron I. Davis bought $20.0M of Odonate Therapeutics, Inc.
Bought$20,000,003
$14.25Price
1,403,509Shares
+35%Stake
What ODT did for a copier
Prices for ODT after this filing aren't in yet.
Aaron I. Davis's record
6 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Aug 28. Filed Tue, Sep 1, 12:30 PM ET, during the session. Not investment advice.